HOLLENCREST CAPITAL MANAGEMENT - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
HOLLENCREST CAPITAL MANAGEMENT ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$3,822,000
+83.0%
82,500
-3.7%
0.48%
+69.0%
Q1 2019$2,088,0000.0%85,6450.0%0.28%0.0%
Q4 2018$2,088,0000.0%85,6450.0%0.28%0.0%
Q3 2018$2,088,000
-12.0%
85,645
-39.5%
0.28%
-10.5%
Q2 2018$2,374,000
+2.8%
141,4700.0%0.31%
+4.0%
Q1 2018$2,309,000
+27.5%
141,4700.0%0.30%
+27.4%
Q4 2017$1,811,000
+4.1%
141,4700.0%0.24%
-1.7%
Q3 2017$1,740,000
+47.0%
141,4700.0%0.24%
+35.4%
Q2 2017$1,184,000
-6.4%
141,4700.0%0.18%
-3.3%
Q1 2017$1,265,000
+1.7%
141,4700.0%0.18%
-2.1%
Q4 2016$1,244,000
+8.4%
141,470
-16.8%
0.19%
+13.3%
Q3 2016$1,148,000
+89.8%
170,0000.0%0.17%
+78.5%
Q2 2016$605,000
+20.5%
170,0000.0%0.09%
+9.4%
Q1 2016$502,000
-30.0%
170,0000.0%0.08%
-33.1%
Q4 2015$717,000
-7.5%
170,0000.0%0.13%
-5.2%
Q3 2015$775,000
-36.8%
170,0000.0%0.13%
-23.9%
Q2 2015$1,226,000
-2.2%
170,0000.0%0.18%
+6.0%
Q1 2015$1,253,000
+55.8%
170,0000.0%0.17%
+56.6%
Q4 2014$804,000
+32.5%
170,0000.0%0.11%
+27.7%
Q3 2014$607,000
-21.7%
170,0000.0%0.08%
-20.2%
Q2 2014$775,000
-3.0%
170,0000.0%0.10%
-11.9%
Q1 2014$799,000
-11.4%
170,000
-5.6%
0.12%
-19.7%
Q4 2013$902,000180,0000.15%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
BVF INC/IL 9,169,276$66,110,00011.67%
Redmile Group, LLC 13,623,620$98,226,0008.05%
First Light Asset Management, LLC 849,374$6,124,0002.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,529,361$68,707,0002.29%
Opus Point Partners Management, LLC 320,000$2,307,0001.83%
KOPP INVESTMENT ADVISORS LLC 383,022$2,762,0001.23%
Artal Group S.A. 3,710,000$26,749,0001.15%
EcoR1 Capital, LLC 400,000$2,884,0000.96%
Cormorant Asset Management, LP 850,000$6,129,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,768,0000.56%
View complete list of ARRAY BIOPHARMA INC shareholders